Improving pain management through medicinal chemistry.
Official title: SUBJECT MATTER EXPERT CONSULTANT FOR MEDICINAL CHEMISTRY. NIH BLUEPRINT NEUROTHERAPEUTICS NETWORK(BPN) AND BPN HEAL, BIOLOGICS.
NIH-11211252 · Data updated 2026-11-12
This study is looking for better ways to manage pain by working with experts to create new treatments that could help you feel better with fewer side effects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project start | July 15, 2024 |
| Project end | July 14, 2025 |
| Funding year | 2024 |
| Award (this year) | $3,920 |
| NIH project number | 75N95024P00334-0-0-1 |
| Project ID | NIH-11211252 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing chronic pain or those who have not found relief with existing pain management therapies.
✕Less likely to help
Patients with acute pain conditions or those not experiencing chronic pain may not benefit from this research.
What this research studies
This research focuses on enhancing our understanding of pain and developing better strategies for pain management. It is part of the NIH’s HEAL initiative, which aims to find scientific solutions to address the complexities of pain. The approach involves consulting with experts in medicinal chemistry to create biologics and biotherapeutic agents that can effectively treat pain. Patients may benefit from new treatments that are more effective and have fewer side effects compared to current options.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management therapies that improve quality of life for patients suffering from chronic pain.
How similar studies have gone: Other research initiatives under the HEAL program have shown promise in developing innovative pain management solutions.
Where this research is happening
Lithia Springs, United States
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.